Fortress Biotech, Inc. (FBIOP) vs Immuneering Corporation (IMRX)

A side-by-side comparison of Fortress Biotech, Inc. and Immuneering Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Fortress Biotech, Inc. logo
FBIOP
Fortress Biotech, Inc.
$140M
$17.75HealthcareDelayed quote: Oct 6, 2026, 10:53 AM EDT
Immuneering Corporation logo
IMRX
Immuneering Corporation
$146M
$4.03HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

Total return — FBIOP vs IMRX

growth of $100 · dividends reinvested · last 5y
FBIOP +0.5% (+0.1%/yr)IMRX -77.0% (-25.5%/yr)FBIOP compounded faster over this window
050100150200Start $10020222023202420252026$100$23
FBIOP IMRX

FBIOP vs IMRX: by the numbers

  • •IMRX is the larger company ($146M vs $140M market cap).
  • •FBIOP is profitable (163.32% net margin) while IMRX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricFBIOPIMRX
P/E ratio6.62N/A
Forward P/E6.96N/A
P/S ratio2.04N/A
P/B ratio0.850.77
FCF yield90.06%N/A

Profitability

MetricFBIOPIMRX
Gross margin62.53%0.00%
Operating margin-111.00%0.00%
Net margin163.32%0.00%
ROE68.12%-30.03%
ROIC-10.85%-32.73%

Growth (annualized)

MetricFBIOPIMRX
Revenue CAGR (5Y)5.39%N/A
Total return CAGR (5Y)0.05%-32.77%

Frequently asked

Is FBIOP or IMRX more profitable?
FBIOP runs the higher net margin — FBIOP at 163.32% versus IMRX at 0.00%.
How have FBIOP and IMRX total returns compared?
Over the past 5 years, FBIOP delivered 0.05% and IMRX delivered -32.77% annualized total return. Past performance doesn't predict future results.

Go deeper

Full FBIOP analysisFull IMRX analysisInteractive comparison tool

Dig into the metrics

Fortress Biotech P/E ratioFortress Biotech ROEImmuneering ROEFortress Biotech operating marginImmuneering operating marginFortress Biotech revenue growthImmuneering revenue growthFortress Biotech free cash flowImmuneering free cash flow

Fortress Biotech & Immuneering appear in these rankings

Highest ROE StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.